All In Biotech

Drug Trial Radar · NCT07089589

Preoperative Statin Use and Major Adverse Cardiovascular Events in Liver Transplant Recipients

Preoperative Statin Use and Major Adverse Cardiovascular Events in Liver Transplant Recipients: A Multicenter Retrospective Cohort Study

Last checked: Nov 19, 2026Latest source record: Apr 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

6,898

Actual

Start

Jan 2, 2008

Primary completion

Jan 25, 2026

Study completion Mar 22, 2026

Sponsor

Lead sponsor
Asan Medical CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Samsung Medical Center; Inje University Haeundae Paik Hospital
First posted
Jul 28, 2025

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this multicenter observational study is to determine whether preoperative statin use reduces major adverse cardiovascular events or other complications after liver transplantation. The main question it aims to answer is: Does preoperative statin use reduce major adverse cardiovascular events or other complications after liver transplantation? The records of participants who already took statins before liver transplantation will be reviewed.

Conditions

  • Major Adverse Cardiovascular Events
  • Liver Transplantation

Interventions

  • Preoperative Statin UseDrug

    Administration of any statin medication prior to liver transplantation. Statin therapy was previously prescribed by the treating physician before the transplant procedure, not assigned by the study protocol.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. 30-day Major Adverse Cardiovascular EventsTime frame: 30 days after liver transplantation

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Asan Medical Center

    Seoul, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.